Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Advancing Lung Cancer Screening: Artificial Intelligence, Multimodal Imaging and Cutting-Edge Technologies for Early Detection and Characterization

NCT06531343 is registered in ClinicalTrials.gov with IRCCS San Raffaele as lead sponsor.

NCT NCT06531343
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06531343 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Advancing Lung Cancer Screening: Artificial Intelligence, Multimodal Imaging and Cutting-Edge Technologies for Early Detection and Characterization
Lead sponsor
IRCCS San Raffaele
Phase
Not applicable
Overall status
Not yet recruiting
Start date
October 30, 2024
Completion date
August 30, 2026
Enrollment
334 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer screening